Gene · 22925
Papers2,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. | Kidney Int Rep | 2026 | 41541780 | PubTator, text mining | PubMed |
| First-line and Second-line Therapy of Zuberitamab in Idiopathic Membranous Nephropathy: A Single-center Retrospective Study. | Kidney Med | 2026 | 41509998 | PubTator, text mining | PubMed |
| Anti-Phospholipase A2 Receptor Antibody Trajectories for Predicting Prognosis in Patients with Phospholipase A2 Receptor-Associated Membranous Nephropathy. | Am J Nephrol | 2026 | 41499338 | PubTator, text mining | PubMed |
| Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy. | J Transl Autoimmun | 2026 | 41497346 | PubTator, text mining | PubMed |
| Integrated sTim-3 and PLA2R-Ab Levels Improve Risk Stratification in PLA2R-Positive Membranous Nephropathy. | Nephron | 2026 | 41493895 | PubTator, text mining | PubMed |
| Serum PLA2R-IgG4/PLA2R-IgG ratio dynamics reveal pathogenic autoantibody subclass switch during progression of PLA2R-associated membranous nephropathy. | Ann Med | 2026 | 41492182 | PubTator, text mining | PubMed |
| Toward precision immunotherapy in nephrology: 1 step forward. | Kidney Int | 2026 | 41485803 | PubTator, text mining | PubMed |
| Delayed onset of systemic lupus erythematosus in patients with idiopathic membranous nephropathy. | Lupus | 2026 | 41416633 | PubTator, text mining | PubMed |
| EXT2 transition in adolescent membranous nephritis. | Pediatr Nephrol | 2026 | 41348129 | PubTator, text mining | PubMed |
| Dual-antigen membranous nephropathy. | Kidney Int | 2026 | 41197955 | PubTator, text mining | PubMed |
| Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cells. | Kidney Int | 2026 | 41177511 | PubTator, text mining | PubMed |
| Earlier Hematuria Negative Conversion Was an Independent Predictor for Nephrotic Remission in Patients with Primary Membranous Nephropathy and Nephrotic Syndrome. | Am J Nephrol | 2026 | 41129416 | PubTator, text mining | PubMed |
| How to Cure Autoimmune GN and Podocytopathies. | J Am Soc Nephrol | 2026 | 41071671 | PubTator, text mining | PubMed |
| Anti-PLA2R IgG4-to-IgG Ratio Helps Predict Remission of PLA2R-Associated Primary Membranous Nephropathy. | Am J Nephrol | 2026 | 40759106 | PubTator, text mining | PubMed |
| Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy. | Am J Nephrol | 2026 | 40388905 | PubTator, text mining | PubMed |
| Recurrence of Glomerular Diseases after Kidney Transplantation: What Do We Know New? | Nephron | 2026 | 39778555 | PubTator, text mining | PubMed |
| The utility of phospholipase A2 receptor antibody in pregnancy: A case report. | Obstet Med | 2026 | 39553180 | PubTator, text mining | PubMed |
| A noninvasive method of diagnosing membranous nephropathy using exosomes derived from urine. | Kidney Res Clin Pract | 2026 | 39384351 | PubTator, text mining | PubMed |
| A beginner's guide to the clinical approach and key concepts of glomerular disease: a mini review. | Asian Biomed (Res Rev News) | 2025 | 41728366 | PubTator, text mining | PubMed |
| Spontaneous inferior epigastric artery hemorrhage in a COVID-19 patient with membranous nephropathy on anticoagulant therapy: a Case Report. | Front Med (Lausanne) | 2025 | 41551501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22925/papers?page=7